INTERNATIONAL VACCINE INSTITUTE: Form 990, tax year 2017

View the entire original 990 at ProPublica ↗

Organization
INTERNATIONAL VACCINE INSTITUTE (EIN 31-1621592)
Tax period
2017-01-01 to 2017-12-31
Filed
2018-07-27
IRS object ID
201812089349300206
Schema version
2017v2.3
Source
Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header ReturnHeader

FieldValueIRS element (for citing)
Return2018-07-27T09:26:12-05:00ReturnTs
Tax Period End2017-12-31TaxPeriodEndDt

Preparer Firm PreparerFirmGrp

Preparer Firm Name PreparerFirmName

FieldValueIRS element (for citing)
Business Name Line1BDO USA LLPBusinessNameLine1Txt

Preparer US Address PreparerUSAddress

FieldValueIRS element (for citing)
Address Line18401 GREENSBORO DRIVE 800AddressLine1Txt
CityMCLEANCityNm
State AbbreviationVAStateAbbreviationCd
ZIP22102ZIPCd
FieldValueIRS element (for citing)
Return Type990ReturnTypeCd
Tax Period Begin2017-01-01TaxPeriodBeginDt

Filer Filer

FieldValueIRS element (for citing)
EIN311621592EIN

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1INTERNATIONAL VACCINE INSTITUTEBusinessNameLine1Txt
FieldValueIRS element (for citing)
In Care Of% EUNHYE LEEInCareOfNm
Business Name ControlINTEBusinessNameControlTxt
Phone8228722803PhoneNum

Foreign Address ForeignAddress

FieldValueIRS element (for citing)
Address Line1snu research park 1 gwanak-roAddressLine1Txt
CityseoulCityNm
CountryKSCountryCd
Foreign Postal151-742ForeignPostalCd

Business Officer BusinessOfficerGrp

FieldValueIRS element (for citing)
PersonPHILIP DRIVERPersonNm
Person TitleDEP DIR OF FIN & OPPersonTitleTxt
Phone7038930600PhoneNum
Signature2018-06-30SignatureDt
Discuss With Paid PreparerYes (true)DiscussWithPaidPreparerInd

Preparer Person PreparerPersonGrp

FieldValueIRS element (for citing)
Preparer PersonJACOB COOKPreparerPersonNm
PTINP01240455PTIN
Phone7038930600PhoneNum
FieldValueIRS element (for citing)
Tax2017TaxYr
Build TS2022-09-23 18:48:47ZBuildTS

Form 990 IRS990

FieldValueIRS element (for citing)
Principal OfficerJEROME H KIMPrincipalOfficerNm

Foreign Address ForeignAddress

FieldValueIRS element (for citing)
Address Line1SNU RESEARCH PARK 1 GWANAK-ROAddressLine1Txt
CitySEOULCityNm
CountryKSCountryCd
Foreign Postal151-742ForeignPostalCd
FieldValueIRS element (for citing)
Gross Receipts$27,796,643GrossReceiptsAmt
Group Return For AffiliatesfalseGroupReturnForAffiliatesInd
Organization501c3Yes (X)Organization501c3Ind
Website Addresswww.ivi.intWebsiteAddressTxt
Type Of Organization CorpYes (X)TypeOfOrganizationCorpInd
Formation1997FormationYr
Activity Or MissionSEE SCHEDULE OActivityOrMissionDesc
Voting Members Governing Body15VotingMembersGoverningBodyCnt
Voting Members Independent10VotingMembersIndependentCnt
Total Employee1TotalEmployeeCnt
Total Volunteers7TotalVolunteersCnt
Total Gross UBI$0TotalGrossUBIAmt
PY Contributions Grants$25,948,268PYContributionsGrantsAmt
CY Contributions Grants$27,484,411CYContributionsGrantsAmt
PY Program Service Revenue$0PYProgramServiceRevenueAmt
CY Program Service Revenue$0CYProgramServiceRevenueAmt
PY Investment Income$49,021PYInvestmentIncomeAmt
CY Investment Income$76,238CYInvestmentIncomeAmt
PY Other Revenue$59,613PYOtherRevenueAmt
CY Other Revenue$235,868CYOtherRevenueAmt
PY Total Revenue$26,056,902PYTotalRevenueAmt
CY Total Revenue$27,796,517CYTotalRevenueAmt
PY Grants And Similar Paid$6,221,631PYGrantsAndSimilarPaidAmt
CY Grants And Similar Paid$7,865,415CYGrantsAndSimilarPaidAmt
PY Benefits Paid To Members$0PYBenefitsPaidToMembersAmt
CY Benefits Paid To Members$0CYBenefitsPaidToMembersAmt
PY Salaries Comp Emp Bnft Paid$10,343,517PYSalariesCompEmpBnftPaidAmt
CY Salaries Comp Emp Bnft Paid$10,302,629CYSalariesCompEmpBnftPaidAmt
PY Total Prof Fndrsng Expns$0PYTotalProfFndrsngExpnsAmt
CY Total Prof Fndrsng Expns$0CYTotalProfFndrsngExpnsAmt
CY Total Fundraising Expense$521,617CYTotalFundraisingExpenseAmt
PY Other Expenses$8,459,876PYOtherExpensesAmt
CY Other Expenses$7,774,133CYOtherExpensesAmt
PY Total Expenses$25,025,024PYTotalExpensesAmt
CY Total Expenses$25,942,177CYTotalExpensesAmt
PY Revenues Less Expenses$1,031,878PYRevenuesLessExpensesAmt
CY Revenues Less Expenses$1,854,340CYRevenuesLessExpensesAmt
Total Assets BOY$23,484,429TotalAssetsBOYAmt
Total Assets EOY$20,916,339TotalAssetsEOYAmt
Total Liabilities BOY$18,538,434TotalLiabilitiesBOYAmt
Total Liabilities EOY$14,043,688TotalLiabilitiesEOYAmt
Net Assets Or Fund Balances BOY$4,945,995NetAssetsOrFundBalancesBOYAmt
Net Assets Or Fund Balances EOY$6,872,651NetAssetsOrFundBalancesEOYAmt
Info In Schedule O Part IIIYes (X)InfoInScheduleOPartIIIInd
MissionSEE SCHEDULE OMissionDesc
Significant New Program SrvcYes (true)SignificantNewProgramSrvcInd
Significant ChangeYes (true)SignificantChangeInd
Expense$3,744,627ExpenseAmt
Grant$1,955,450GrantAmt
DescVaccine Development against MERS-CoV Since IVI launched the MERS Program in late 2015 with funding from the Samsung Life Public Welfare Foundation, IVI continues to work on accelerating the development of MERS vaccines, with the aim of demonstrating the safety and immunogenicity of two MERS vaccines in Phase II trials conducted in South Korea. IVI and GeneOne Life Sciences signed a Collaboration and Access Agreement to support GeneOnes MERS DNA vaccine candidate in late 2016, and Phase I/IIa clinical trials for GeneOnes vaccine were approved by the Korean Ministry of Food and Drug Safety (KMFDS) in 2017. The toxicity study, required by KMFDS as part of their IND approval, was initiated in Dec 2017. IVI also kept engaging with a donor and vaccine developers to select 2nd candidate MERS-CoV vaccine in addition to GeneOne DNA vaccine, through landscape analysis. Other than clinical studies, an epidemiological study was initiated in 2017 to develop and analyze a dynamic model of MERS-CoV transmission in Korea, which would support the Korean regulatory bodies to make effective strategies on MERS-CoV vaccination and vaccine stockpiling. BSL-3 facilities were re-certified in mid-2017 and would be operated for laboratory testing on MERS-CoV clinical samples.Desc

Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp

FieldValueIRS element (for citing)
Expense$2,783,099ExpenseAmt
Grant$1,015,168GrantAmt
DescSevere Typhoid in Africa(SETA) SETA is a follow-up grant of TSAP funded by The Bill and Melinda Gates Foundation. It aims to estimate the burden, severity, immune response, long-term sequelae and the associated costs of invasive Salmonella infections in sub-Saharan Africa. Network of surveillance sites across 6 countries in sSA is set up and activities are on-going in all SETA countries: Madagascar (Antananarivo, Imerintsiatosika), Burkina Faso (Ouagadougou, Polesgo, Nioko), Ghana (Agogo, Kumasi), Nigeria (Ibadan), Ethiopia (Adama Wenji and Welayita Sodo), and DRC (Kisantu.) As of December 31, 2017, a total of 202,902 patients had been screened from all participating sites. From these screened patients, 5% (10,137/201,570) met the study inclusion criteria of which 76% (7,695/10,137) were enrolled in SETADesc

Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp

FieldValueIRS element (for citing)
Expense$3,343,014ExpenseAmt
Grant$1,981,519GrantAmt
DescVi-DT clinical development support for SK Chemicals We developed a typhoid conjugate vaccine using platform technology from the U.S. National Institutes of Health, conjugating the Salmonella Typhi Vi polysaccharide to diphtheria toxoid (Vi-DT). Conjugate vaccines have the advantage of conferring protection to infants (a high-risk group) against typhoid as well as generating T-cell-based immune responses. IVI transferred this technology to SK Chemicals in South Korea in 2013 and received grants from the Gates Foundation to work with SK Chemicals (IVI is leading clinical development). This collaboration aims to obtain vaccine licensure and then receive WHO prequalification for procurement in the Gavi/ UNICEF market. -Phase I clinical trial for SK Vi-DT was completed in Manila, the Philippines. There were 144 study participants enrolled. The trial showed no vaccine safety concerns and a 100% seroconversion rate. -Phase II clinical trials is in progress and exploratory steps for a Phase III trial have been undertaken.Desc
FieldValueIRS element (for citing)
Total Other Prog Srvc Expense$11,538,776TotalOtherProgSrvcExpenseAmt
Total Other Prog Srvc Grant$2,913,278TotalOtherProgSrvcGrantAmt
Total Program Service Expenses$21,409,516TotalProgramServiceExpensesAmt
Described In Section501c3Yes (true)DescribedInSection501c3Ind
Schedule B RequiredYes (true)ScheduleBRequiredInd
Political Campaign ActyfalsePoliticalCampaignActyInd
Lobbying ActivitiesfalseLobbyingActivitiesInd
Subject To Proxy TaxfalseSubjectToProxyTaxInd
Donor Advised FundfalseDonorAdvisedFundInd
Conservation EasementsfalseConservationEasementsInd
Collections Of ArtfalseCollectionsOfArtInd
Credit CounselingfalseCreditCounselingInd
Temp Or Permanent EndowmentsfalseTempOrPermanentEndowmentsInd
Report Land Building EquipmentYes (true)ReportLandBuildingEquipmentInd
Report Investments Other SecfalseReportInvestmentsOtherSecInd
Report Program Related InvstfalseReportProgramRelatedInvstInd
Report Other AssetsfalseReportOtherAssetsInd
Report Other LiabilitiesYes (true)ReportOtherLiabilitiesInd
Include FIN48 FootnotefalseIncludeFIN48FootnoteInd
Independent Audit Fincl StmtYes (true)IndependentAuditFinclStmtInd
Consolidated Audit Fincl StmtfalseConsolidatedAuditFinclStmtInd
School OperatingfalseSchoolOperatingInd
Foreign OfficeYes (true)ForeignOfficeInd
Foreign ActivitiesYes (true)ForeignActivitiesInd
More Than5000 K To OrgYes (true)MoreThan5000KToOrgInd
More Than5000 K To IndividualsfalseMoreThan5000KToIndividualsInd
Professional FundraisingfalseProfessionalFundraisingInd
Fundraising ActivitiesYes (true)FundraisingActivitiesInd
Gaming ActivitiesfalseGamingActivitiesInd
Operate HospitalfalseOperateHospitalInd
Grants To OrganizationsYes (true)GrantsToOrganizationsInd
Grants To IndividualsfalseGrantsToIndividualsInd
Schedule J RequiredYes (true)ScheduleJRequiredInd
Tax Exempt BondsfalseTaxExemptBondsInd
Engaged In Excess Benefit TransfalseEngagedInExcessBenefitTransInd
PY Excess Benefit TransfalsePYExcessBenefitTransInd
Loan OutstandingYes (true)LoanOutstandingInd
Grant To Related PersonfalseGrantToRelatedPersonInd
Business Rln With Org MemfalseBusinessRlnWithOrgMemInd
Business Rln With Fam MemfalseBusinessRlnWithFamMemInd
Business Rln With Officer EntfalseBusinessRlnWithOfficerEntInd
Deductible Non Cash ContriYes (true)DeductibleNonCashContriInd
Deductible Art ContributionfalseDeductibleArtContributionInd
Terminate OperationsfalseTerminateOperationsInd
Partial LiquidationfalsePartialLiquidationInd
Disregarded EntityfalseDisregardedEntityInd
Related EntityfalseRelatedEntityInd
Related Organization Ctrl EntfalseRelatedOrganizationCtrlEntInd
Trnsfr Exmpt Non Chrtbl Rltd OrgfalseTrnsfrExmptNonChrtblRltdOrgInd
Activities Conducted PrtshpfalseActivitiesConductedPrtshpInd
Schedule O RequiredYes (true)ScheduleORequiredInd
Info In Schedule O Part VYes (X)InfoInScheduleOPartVInd
IRP Document0IRPDocumentCnt
IRP Document W2 G0IRPDocumentW2GCnt
Employee1EmployeeCnt
Employment Tax Returns FiledYes (true)EmploymentTaxReturnsFiledInd
Unrelated Bus Incm Over LimitfalseUnrelatedBusIncmOverLimitInd
Foreign Financial AccountYes (true)ForeignFinancialAccountInd
Foreign CountryKSForeignCountryCd
Prohibited Tax Shelter TransfalseProhibitedTaxShelterTransInd
Taxable Party NotificationfalseTaxablePartyNotificationInd
Nondeductible ContributionsfalseNondeductibleContributionsInd
Quid Pro Quo ContributionsfalseQuidProQuoContributionsInd
Form8282 Property Disposed OffalseForm8282PropertyDisposedOfInd
Rcv Fnds To Pay Prsnl Bnft CntrctfalseRcvFndsToPayPrsnlBnftCntrctInd
Pay Premiums Prsnl Bnft CntrctfalsePayPremiumsPrsnlBnftCntrctInd
Indoor Tanning ServicesfalseIndoorTanningServicesInd
Info In Schedule O Part VIYes (X)InfoInScheduleOPartVIInd
Governing Body Voting Members15GoverningBodyVotingMembersCnt
Independent Voting Member10IndependentVotingMemberCnt
Family Or Business RlnYes (true)FamilyOrBusinessRlnInd
Delegation Of Mgmt DutiesfalseDelegationOfMgmtDutiesInd
Change To Org DocumentsfalseChangeToOrgDocumentsInd
Material Diversion Or MisusefalseMaterialDiversionOrMisuseInd
Members Or StockholdersfalseMembersOrStockholdersInd
Election Of Board MembersYes (true)ElectionOfBoardMembersInd
Decisions Subject To ApprovafalseDecisionsSubjectToApprovaInd
Minutes Of Governing BodyYes (true)MinutesOfGoverningBodyInd
Minutes Of CommitteesYes (true)MinutesOfCommitteesInd
Officer Mailing AddressfalseOfficerMailingAddressInd
Local ChaptersfalseLocalChaptersInd
Form990 Provided To Gvrn BodyfalseForm990ProvidedToGvrnBodyInd
Conflict Of Interest PolicyYes (true)ConflictOfInterestPolicyInd
Annual Disclosure Covered PrsnYes (true)AnnualDisclosureCoveredPrsnInd
Regular Monitoring EnfrcYes (true)RegularMonitoringEnfrcInd
Whistleblower PolicyYes (true)WhistleblowerPolicyInd
Document Retention PolicyYes (true)DocumentRetentionPolicyInd
Compensation Process CEOYes (true)CompensationProcessCEOInd
Compensation Process OtherYes (true)CompensationProcessOtherInd
Investment In Joint VenturefalseInvestmentInJointVentureInd
Upon RequestYes (X)UponRequestInd

Books In Care Of Detail BooksInCareOfDetail

FieldValueIRS element (for citing)
PersonEUNHYE LEEPersonNm
Phone8228722803PhoneNum

Foreign Address ForeignAddress

FieldValueIRS element (for citing)
Address Line1snu research park 1 gwanak-roAddressLine1Txt
Province Or Stategwanak-gu, seoulProvinceOrStateNm
CountryKSCountryCd
Foreign Postal151-742ForeignPostalCd

Form990 Part VII Section A Form990PartVIISectionAGrp (23 entries)

TitleTitleTxtAverage Hours Per WeekAverageHoursPerWeekRtAverage Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRtIndividual Trustee Or DirectorIndividualTrusteeOrDirectorIndReportable Comp From OrgReportableCompFromOrgAmtReportable Comp From Rltd OrgReportableCompFromRltdOrgAmtOther CompensationOtherCompensationAmtOfficerOfficerIndKey EmployeeKeyEmployeeIndHighest Compensated EmployeeHighestCompensatedEmployeeInd
Adel AF Mahmoud
Chairman / Board of Trustee1.00.0Yes (X)$750$0$0
George Bickerstaff
Director / Board of Trustee1.00.0Yes (X)$796$0$0
George Siber
Director / Board of Trustee1.00.0Yes (X)$1,546$0$0
Joseph Kim
Director / Board of Trustee1.00.0Yes (X)$1,638$0$0
Hanna Nohynek
Director / Board of Trustee1.00.0Yes (X)$1,638$0$0
Fred Binka
Director / Board of Trustee1.00.0Yes (X)$1,776$0$0
Lee Kyu Hyung
Director / Board of Trustee1.00.0Yes (X)$750$0$0
Jee Youngmee
Director / Board of Trustee1.00.0Yes (X)$1,500$0$0
Jerome Kim
Director General40.00.0Yes (X)$651,772$0$149,211Yes (X)
LEE JANGKEUN
Director / Board of Trustee1.00.0Yes (X)$0$0$0
ROS-MARI BALOW
Director / Board of Trustee1.00.0Yes (X)$0$0$0
CHRIS VARMA
Director / Board of Trustee1.00.0Yes (X)$0$0$0
MALCOLM SWEENEY
Director / Board of Trustee1.00.0Yes (X)$0$0$0
SHIN YOUNGSOO
Director / Board of Trustee1.00.0Yes (X)$0$0$0
SANJAY MADHAV MEHENDALE
Director / Board of Trustee1.00.0Yes (X)$0$0$0
Phil Driver
Deputy Dir. Gen of Fin & Ops40.00.0$331,661$0$3,919Yes (X)
Julia Lynch
Deputy Dir. Gen of Dev & delvy40.00.0$389,071$0$60,344Yes (X)
In Kyu Yoon
Program Director, MERS and GDA40.00.0$308,380$0$72,590Yes (X)
Viliam Pavliak
Head of Vaccine Process Dev40.00.0$264,022$0$46,120Yes (X)
Jean-Louis Excler
Head of Clinical Dev & Reg.40.00.0$221,133$0$8,210Yes (X)
Yun Chon
Head of Biostatistics & Data40.00.0$217,822$0$36,753Yes (X)
Kyung-Taik Han
Deputy Dir. Gen of Gov Affairs40.00.0$209,706$0$774Yes (X)
Manki Song
Head of Clinical Research Lab40.00.0$193,399$0$4,025Yes (X)
FieldValueIRS element (for citing)
Total Reportable Comp From Org$2,797,360TotalReportableCompFromOrgAmt
Tot Reportable Comp Rltd Org$0TotReportableCompRltdOrgAmt
Total Other Compensation$381,946TotalOtherCompensationAmt
Indiv Rcvd Greater Than100 K19IndivRcvdGreaterThan100KCnt
Former Ofcr Employees ListedfalseFormerOfcrEmployeesListedInd
Total Comp Greater Than150 KYes (true)TotalCompGreaterThan150KInd
Compensation From Other SrcsfalseCompensationFromOtherSrcsInd

Contractor Compensation ContractorCompensationGrp

Contractor Name ContractorName

FieldValueIRS element (for citing)
PersonThe Boston Consulting Group IncPersonNm

Contractor Address ContractorAddress

US Address USAddress

FieldValueIRS element (for citing)
Address Line1PO box 75200AddressLine1Txt
CityCHICAGOCityNm
State AbbreviationILStateAbbreviationCd
ZIP606755200ZIPCd
FieldValueIRS element (for citing)
ServicesCONSULTINGServicesDesc
Compensation$1,112,476CompensationAmt
FieldValueIRS element (for citing)
Cntrct Rcvd Greater Than100 K1CntrctRcvdGreaterThan100KCnt
Fundraising$28,754FundraisingAmt
Government Grants$5,842,234GovernmentGrantsAmt
All Other Contributions$21,613,423AllOtherContributionsAmt
Noncash Contributions$26,338NoncashContributionsAmt
Total Contributions$27,484,411TotalContributionsAmt
Total Program Service Revenue$0TotalProgramServiceRevenueAmt

Investment Income InvestmentIncomeGrp

FieldValueIRS element (for citing)
Total Revenue Column$76,238TotalRevenueColumnAmt
Exclusion$76,238ExclusionAmt

Incm From Invest Bond Proceeds IncmFromInvestBondProceedsGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt

Royalties Revenue RoyaltiesRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt

Rental Income Or Loss RentalIncomeOrLossGrp

FieldValueIRS element (for citing)
Real$0RealAmt
Personal$0PersonalAmt

Net Rental Income Or Loss NetRentalIncomeOrLossGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt

Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt
FieldValueIRS element (for citing)
Fundraising Gross Income$259FundraisingGrossIncomeAmt
Contri Rpt Fundraising Event$28,754ContriRptFundraisingEventAmt
Fundraising Direct Expenses$126FundraisingDirectExpensesAmt

Net Incm From Fundraising Evt NetIncmFromFundraisingEvtGrp

FieldValueIRS element (for citing)
Total Revenue Column$133TotalRevenueColumnAmt
Exclusion$133ExclusionAmt
FieldValueIRS element (for citing)
Gaming Gross Income$0GamingGrossIncomeAmt
Gaming Direct Expenses$0GamingDirectExpensesAmt

Net Income From Gaming NetIncomeFromGamingGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt
FieldValueIRS element (for citing)
Gross Sales Of Inventory$0GrossSalesOfInventoryAmt
Cost Of Goods Sold$0CostOfGoodsSoldAmt

Net Income Or Loss NetIncomeOrLossGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt

Other Revenue Misc OtherRevenueMiscGrp (3 entries)

DescDescBusinessBusinessCdTotal Revenue ColumnTotalRevenueColumnAmtExclusionExclusionAmt
MISCELLANEOUS REVENUE900099$12,141$12,141
PAYBACK FROM GENERALI900099$27,350$27,350
RENTAL FOR RESEARCH COLLABORATION900099$196,244$196,244
FieldValueIRS element (for citing)
Other Revenue Total$235,735OtherRevenueTotalAmt

Total Revenue TotalRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$27,796,517TotalRevenueColumnAmt
Exclusion$312,106ExclusionAmt

Grants To Domestic Orgs GrantsToDomesticOrgsGrp

FieldValueIRS element (for citing)
Total$353,631TotalAmt
Program Services$353,631ProgramServicesAmt

Grants To Domestic Individuals GrantsToDomesticIndividualsGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Foreign Grants ForeignGrantsGrp

FieldValueIRS element (for citing)
Total$7,511,784TotalAmt
Program Services$7,511,784ProgramServicesAmt

Benefits To Members BenefitsToMembersGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp

FieldValueIRS element (for citing)
Total$4,893,419TotalAmt
Program Services$2,705,459ProgramServicesAmt
Management And General$2,064,251ManagementAndGeneralAmt
Fundraising$123,709FundraisingAmt

Comp Disqual Persons CompDisqualPersonsGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Other Salaries And Wages OtherSalariesAndWagesGrp

FieldValueIRS element (for citing)
Total$4,349,796TotalAmt
Program Services$2,815,006ProgramServicesAmt
Management And General$1,301,914ManagementAndGeneralAmt
Fundraising$232,876FundraisingAmt

Pension Plan Contributions PensionPlanContributionsGrp

FieldValueIRS element (for citing)
Total$619,651TotalAmt
Program Services$375,654ProgramServicesAmt
Management And General$209,683ManagementAndGeneralAmt
Fundraising$34,314FundraisingAmt

Other Employee Benefits OtherEmployeeBenefitsGrp

FieldValueIRS element (for citing)
Total$283,409TotalAmt
Program Services$143,431ProgramServicesAmt
Management And General$130,068ManagementAndGeneralAmt
Fundraising$9,910FundraisingAmt

Payroll Taxes PayrollTaxesGrp

FieldValueIRS element (for citing)
Total$156,354TotalAmt
Program Services$95,468ProgramServicesAmt
Management And General$53,481ManagementAndGeneralAmt
Fundraising$7,405FundraisingAmt

Fees For Services Management FeesForServicesManagementGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Fees For Services Legal FeesForServicesLegalGrp

FieldValueIRS element (for citing)
Total$170,761TotalAmt
Program Services$51,191ProgramServicesAmt
Management And General$119,570ManagementAndGeneralAmt

Fees For Services Accounting FeesForServicesAccountingGrp

FieldValueIRS element (for citing)
Total$85,551TotalAmt
Program Services$2,615ProgramServicesAmt
Management And General$82,936ManagementAndGeneralAmt

Fees For Services Lobbying FeesForServicesLobbyingGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Fees For Services Prof Fundraising FeesForServicesProfFundraising

FieldValueIRS element (for citing)
Total$0TotalAmt

Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Fees For Services Other FeesForServicesOtherGrp

FieldValueIRS element (for citing)
Total$2,139,046TotalAmt
Program Services$1,769,321ProgramServicesAmt
Management And General$282,190ManagementAndGeneralAmt
Fundraising$87,535FundraisingAmt

Advertising AdvertisingGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Office Expenses OfficeExpensesGrp

FieldValueIRS element (for citing)
Total$233,165TotalAmt
Program Services$161,962ProgramServicesAmt
Management And General$64,108ManagementAndGeneralAmt
Fundraising$7,095FundraisingAmt

Information Technology InformationTechnologyGrp

FieldValueIRS element (for citing)
Total$286,837TotalAmt
Program Services$259,871ProgramServicesAmt
Management And General$26,316ManagementAndGeneralAmt
Fundraising$650FundraisingAmt

Royalties RoyaltiesGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Occupancy OccupancyGrp

FieldValueIRS element (for citing)
Total$1,419,811TotalAmt
Management And General$1,419,811ManagementAndGeneralAmt

Travel TravelGrp

FieldValueIRS element (for citing)
Total$1,401,566TotalAmt
Program Services$1,223,478ProgramServicesAmt
Management And General$176,187ManagementAndGeneralAmt
Fundraising$1,901FundraisingAmt

Pymt Travel Entrtnmnt Pub Ofcl PymtTravelEntrtnmntPubOfclGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Conferences Meetings ConferencesMeetingsGrp

FieldValueIRS element (for citing)
Total$362,432TotalAmt
Program Services$299,338ProgramServicesAmt
Management And General$52,588ManagementAndGeneralAmt
Fundraising$10,506FundraisingAmt

Interest InterestGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Payments To Affiliates PaymentsToAffiliatesGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Depreciation Depletion DepreciationDepletionGrp

FieldValueIRS element (for citing)
Total$207,468TotalAmt
Management And General$207,468ManagementAndGeneralAmt

Insurance InsuranceGrp

FieldValueIRS element (for citing)
Total$57,720TotalAmt
Program Services$31,124ProgramServicesAmt
Management And General$26,596ManagementAndGeneralAmt

Other Expenses OtherExpensesGrp (4 entries)

DescDescTotalTotalAmtProgram ServicesProgramServicesAmtManagement And GeneralManagementAndGeneralAmtFundraisingFundraisingAmt
LAB SUPPLIES$1,264,630$1,248,232$16,398
REPAIRS AND MAINTENANCE$98,521$16,115$82,406
TRAINING$25,990$19,557$6,304$129
ALLOCATION OF INDIRECT COSTS$2,319,480-$2,319,480

All Other Expenses AllOtherExpensesGrp

FieldValueIRS element (for citing)
Total$20,635TotalAmt
Program Services$6,799ProgramServicesAmt
Management And General$8,249ManagementAndGeneralAmt
Fundraising$5,587FundraisingAmt

Total Functional Expenses TotalFunctionalExpensesGrp

FieldValueIRS element (for citing)
Total$25,942,177TotalAmt
Program Services$21,409,516ProgramServicesAmt
Management And General$4,011,044ManagementAndGeneralAmt
Fundraising$521,617FundraisingAmt

Cash Non Interest Bearing CashNonInterestBearingGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Savings And Temp Cash Invst SavingsAndTempCashInvstGrp

FieldValueIRS element (for citing)
BOY$21,637,741BOYAmt
EOY$19,061,316EOYAmt

Pledges And Grants Receivable PledgesAndGrantsReceivableGrp

FieldValueIRS element (for citing)
BOY$27,359BOYAmt
EOY$81,190EOYAmt

Accounts Receivable AccountsReceivableGrp

FieldValueIRS element (for citing)
BOY$19,126BOYAmt
EOY$24,709EOYAmt

Receivables From Officers Etc ReceivablesFromOfficersEtcGrp

FieldValueIRS element (for citing)
BOY$229,190BOYAmt
EOY$140,545EOYAmt

Rcvbl From Disqualified Prsn RcvblFromDisqualifiedPrsnGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Oth Notes Loans Receivable Net OthNotesLoansReceivableNetGrp

FieldValueIRS element (for citing)
BOY$98,927BOYAmt
EOY$102,974EOYAmt

Inventories For Sale Or Use InventoriesForSaleOrUseGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp

FieldValueIRS element (for citing)
BOY$407,788BOYAmt
EOY$229,986EOYAmt
FieldValueIRS element (for citing)
Land Bldg Equip Cost Or Other Bss$8,249,560LandBldgEquipCostOrOtherBssAmt
Land Bldg Equip Accum Deprec$6,978,187LandBldgEquipAccumDeprecAmt

Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp

FieldValueIRS element (for citing)
BOY$1,060,052BOYAmt
EOY$1,271,373EOYAmt

Investments Pub Traded Sec InvestmentsPubTradedSecGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Investments Other Securities InvestmentsOtherSecuritiesGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Investments Program Related InvestmentsProgramRelatedGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Intangible Assets IntangibleAssetsGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Other Assets Total OtherAssetsTotalGrp

FieldValueIRS element (for citing)
BOY$4,246BOYAmt
EOY$4,246EOYAmt

Total Assets TotalAssetsGrp

FieldValueIRS element (for citing)
BOY$23,484,429BOYAmt
EOY$20,916,339EOYAmt

Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp

FieldValueIRS element (for citing)
BOY$2,734,583BOYAmt
EOY$1,469,522EOYAmt

Grants Payable GrantsPayableGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Deferred Revenue DeferredRevenueGrp

FieldValueIRS element (for citing)
BOY$15,803,851BOYAmt
EOY$11,557,615EOYAmt

Tax Exempt Bond Liabilities TaxExemptBondLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Escrow Account Liability EscrowAccountLiabilityGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Loans From Officers Directors LoansFromOfficersDirectorsGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Mortg Notes Pybl Scrd Invst Prop MortgNotesPyblScrdInvstPropGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Unsecured Notes Loans Payable UnsecuredNotesLoansPayableGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Other Liabilities OtherLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$1,016,551EOYAmt

Total Liabilities TotalLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$18,538,434BOYAmt
EOY$14,043,688EOYAmt
FieldValueIRS element (for citing)
Org Does Not Follow SFAS117Yes (X)OrgDoesNotFollowSFAS117Ind

Cap Stk Tr Prin Current Funds CapStkTrPrinCurrentFundsGrp

FieldValueIRS element (for citing)
BOY$2,233,833BOYAmt
EOY$4,160,489EOYAmt

Pd In Cap Srpls Land Bldg Eqp Fund PdInCapSrplsLandBldgEqpFundGrp

FieldValueIRS element (for citing)
BOY$2,712,162BOYAmt
EOY$2,712,162EOYAmt

Rtn Earn Endowment Incm Oth Fnds RtnEarnEndowmentIncmOthFndsGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$4,945,995BOYAmt
EOY$6,872,651EOYAmt

Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$23,484,429BOYAmt
EOY$20,916,339EOYAmt
FieldValueIRS element (for citing)
Info In Schedule O Part XIYes (X)InfoInScheduleOPartXIInd
Reconcilation Revenue Expnss$1,854,340ReconcilationRevenueExpnssAmt
Other Changes In Net Assets$72,316OtherChangesInNetAssetsAmt
Method Of Accounting AccrualYes (X)MethodOfAccountingAccrualInd
Accountant Compile Or ReviewfalseAccountantCompileOrReviewInd
FS AuditedYes (true)FSAuditedInd

FS Audited Basis FSAuditedBasisGrp

FieldValueIRS element (for citing)
Separate Basis Fincl StmtYes (X)SeparateBasisFinclStmtInd
FieldValueIRS element (for citing)
Audit CommitteeYes (true)AuditCommitteeInd
Federal Grant Audit RequiredfalseFederalGrantAuditRequiredInd

Schedule A IRS990ScheduleA

FieldValueIRS element (for citing)
Public Organization170Yes (X)PublicOrganization170Ind

Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$19,680,492CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$23,508,996CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$21,104,491CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$25,948,268CurrentTaxYearMinus1YearAmt
Current Tax Year$27,484,411CurrentTaxYearAmt
Total$117,726,658TotalAmt

Tax Rev Levied Orgnztnl Bnft170 TaxRevLeviedOrgnztnlBnft170Grp

FieldValueIRS element (for citing)
Total$0TotalAmt

Govt Furn Srvc Fclts Vl170 GovtFurnSrvcFcltsVl170Grp

FieldValueIRS element (for citing)
Total$0TotalAmt

Total Calendar Year170 TotalCalendarYear170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$19,680,492CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$23,508,996CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$21,104,491CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$25,948,268CurrentTaxYearMinus1YearAmt
Current Tax Year$27,484,411CurrentTaxYearAmt
Total$117,726,658TotalAmt
FieldValueIRS element (for citing)
Substantial Contributors Tot$48,532,298SubstantialContributorsTotAmt
Public Support Total170$69,194,360PublicSupportTotal170Amt

Gross Investment Income170 GrossInvestmentIncome170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$8,163CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$72,912CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$35,005CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$49,021CurrentTaxYearMinus1YearAmt
Current Tax Year$76,238CurrentTaxYearAmt
Total$241,339TotalAmt

Unrelated Business Net Incm170 UnrelatedBusinessNetIncm170Grp

FieldValueIRS element (for citing)
Total$0TotalAmt

Other Income170 OtherIncome170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$13,778CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$28,581CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$15,859CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$63,086CurrentTaxYearMinus1YearAmt
Current Tax Year$235,735CurrentTaxYearAmt
Total$357,039TotalAmt
FieldValueIRS element (for citing)
Total Support$118,325,036TotalSupportAmt
Gross Receipts Rltd Activities$9,845GrossReceiptsRltdActivitiesAmt
Public Support CY1700.58478PublicSupportCY170Pct
Public Support PY1700.56180PublicSupportPY170Pct
Thirty Thr Pct Suprt Tests CY170Yes (X)ThirtyThrPctSuprtTestsCY170Ind

Schedule B IRS990ScheduleB

Contributor Information ContributorInformationGrp

FieldValueIRS element (for citing)
ContributorRESTRICTEDContributorNum

Contributor Business Name ContributorBusinessName

FieldValueIRS element (for citing)
Business Name Line1RESTRICTEDBusinessNameLine1

Contributor US Address ContributorUSAddress

FieldValueIRS element (for citing)
Address Line1RESTRICTEDAddressLine1
Address Line2RESTRICTEDAddressLine2
CityRESTRICTEDCity
StateRESTRICTEDState
ZIP CodeRESTRICTEDZIPCode
FieldValueIRS element (for citing)
Total ContributionsRESTRICTEDTotalContributionsAmt

Schedule D IRS990ScheduleD

FieldValueIRS element (for citing)
Art Public Exhibition AmountsArtPublicExhibitionAmountsGrp
Held Works ArtHeldWorksArtGrp
CY Minus3 Yr Endwmt FundCYMinus3YrEndwmtFundGrp
CY Minus4 Yr Endwmt FundCYMinus4YrEndwmtFundGrp
LandLandGrp
BuildingsBuildingsGrp
Leasehold ImprovementsLeaseholdImprovementsGrp

Equipment EquipmentGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$8,178,907OtherCostOrOtherBasisAmt
Depreciation$6,907,534DepreciationAmt
Book Value$1,271,373BookValueAmt

Other Land Buildings OtherLandBuildingsGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$70,653OtherCostOrOtherBasisAmt
Depreciation$70,653DepreciationAmt
Book Value$0BookValueAmt
FieldValueIRS element (for citing)
Total Book Value Land Buildings$1,271,373TotalBookValueLandBuildingsAmt
Federal Income Tax Liability$0FederalIncomeTaxLiabilityAmt

Other Liabilities Org OtherLiabilitiesOrgGrp (2 entries)

DescDescAmtAmt
ADVANCE FUND FROM SIDA$885,196
SECURITY DEPOSIT$131,355
FieldValueIRS element (for citing)
Total Liability$1,016,551TotalLiabilityAmt
Total Rev Etc Audited Fincl Stmt$27,796,643TotalRevEtcAuditedFinclStmtAmt
Revenue Subtotal$27,796,643RevenueSubtotalAmt
Other Revenues Not Included-$126OtherRevenuesNotIncludedAmt
Revenue Not Reported Fincl Stmt-$126RevenueNotReportedFinclStmtAmt
Total Revenue Per Form990$27,796,517TotalRevenuePerForm990Amt
Tot Expns Etc Audited Fincl Stmt$25,942,303TotExpnsEtcAuditedFinclStmtAmt
Other Expenses Included$126OtherExpensesIncludedAmt
Expenses Not Reported$126ExpensesNotReportedAmt
Expenses Subtotal$25,942,177ExpensesSubtotalAmt
Total Expenses Per Form990$25,942,177TotalExpensesPerForm990Amt

Supplemental Information Detail SupplementalInformationDetail (2 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
Part XI, Line 4B:Cost of Goods Sold (126)
Part XII, Line 2D:Cost of Goods Sold 126

Schedule F IRS990ScheduleF

FieldValueIRS element (for citing)
Grant Records MaintainedYes (true)GrantRecordsMaintainedInd

Account Activities Outside US AccountActivitiesOutsideUSGrp (5 entries)

RegionRegionTxtOfficesOfficesCntEmployeeEmployeeCntType Of Activities ConductedTypeOfActivitiesConductedTxtSpecific Services ProvidedSpecificServicesProvidedTxtRegion Total ExpendituresRegionTotalExpendituresAmt
East Asia and the Pacific1126Program ServicesProgram Service$15,058,791
East Asia and the PacificGrantmaking$4,157,935
Europe (Including Iceland and Greenland)Grantmaking$672,933
South AsiaGrantmaking$1,162,304
Sub-Saharan AfricaGrantmaking$1,518,611
FieldValueIRS element (for citing)
Subtotal Offices1SubtotalOfficesCnt
Subtotal Employees126SubtotalEmployeesCnt
Total Office1TotalOfficeCnt
Total Employee126TotalEmployeeCnt
Subtotal Spent$22,570,574SubtotalSpentAmt
Total Spent$22,570,574TotalSpentAmt

Grants To Org Outside US GrantsToOrgOutsideUSGrp (32 entries)

RegionRegionTxtPurpose Of GrantPurposeOfGrantTxtCash GrantCashGrantAmtManner Of Cash DisbursementMannerOfCashDisbursementTxt
East Asia and the PacificProgram service$1,955,450Wire
East Asia and the PacificProgram service$1,750,000Wire
South AsiaProgram service$1,139,225Wire
Sub-Saharan AfricaProgram service$476,100Wire
Europe (Including Iceland and Greenland)Program service$227,091Wire
Sub-Saharan AfricaProgram service$219,154Wire
Sub-Saharan AfricaProgram service$191,455Wire
East Asia and the PacificProgram service$180,490Wire
Europe (Including Iceland and Greenland)Program service$160,850Wire
Sub-Saharan AfricaProgram service$150,233Wire
Europe (Including Iceland and Greenland)Program service$137,135Wire
Sub-Saharan AfricaProgram service$112,415Wire
Sub-Saharan AfricaProgram service$104,420Wire
Europe (Including Iceland and Greenland)Program service$97,086Wire
East Asia and the PacificProgram service$86,950Wire
Sub-Saharan AfricaProgram service$80,975Wire
Sub-Saharan AfricaProgram service$60,693Wire
East Asia and the PacificProgram service$58,564Wire
East Asia and the PacificProgram service$40,855Wire
Sub-Saharan AfricaProgram service$37,740Wire
Europe (Including Iceland and Greenland)Program service$36,369Wire
East Asia and the PacificProgram service$30,000Wire
Sub-Saharan AfricaProgram service$29,105Wire
Sub-Saharan AfricaProgram service$27,359Wire
East Asia and the PacificProgram service$21,867Wire
Sub-Saharan AfricaProgram service$18,913Wire
South AsiaProgram service$18,869Wire
Europe (Including Iceland and Greenland)Program service$13,178Wire
East Asia and the PacificProgram service$8,058Wire
East Asia and the PacificProgram service$7,136Wire
Sub-Saharan AfricaProgram service$6,815Wire
East Asia and the PacificProgram service$6,050Wire
FieldValueIRS element (for citing)
Total501c3 Org32Total501c3OrgCnt
Transfer To Foreign CorpfalseTransferToForeignCorpInd
Interest In Foreign TrustfalseInterestInForeignTrustInd
Foreign Corp OwnershipfalseForeignCorpOwnershipInd
Passive Foreign Investmest CofalsePassiveForeignInvestmestCoInd
Foreign PartnershipfalseForeignPartnershipInd
Boycott CountriesfalseBoycottCountriesInd

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferenceMONITORING GRANTS OUTSIDE THE USFormAndLineReferenceDesc
ExplanationTHE IVI IS LOCATED IN SEOUL, KOREA WHERE ALL THE GRANT FUNDS ARE MANAGED AND EXECUTED. THE IVI HAS IN PLACE A VERY DETAILED AND RIGOROUS SYSTEM OF FINANCIAL MONITORING. THIS SYSTEM, WHICH IS EVALUATED BY INTERNAL FINANCE PERSONNEL THROUGHOUT THE YEAR AND AUDITED EXTERNALLY EVERY YEAR, IS USED IN CONJUNCTION WITH CAREFUL PROJECT DEVELOPMENT AND IMPLEMENTATION TO ENSURE ACCOUNTABILITY AND BUDGETARY MANAGEMENT RESPONSIBILITY. FOR SUBGRANTS, THE IVI HAS A BROAD OVERALL SYSTEM OF REVIEWING AND TRACKING THE USE OF GRANTS, AND MORE SPECIFIC DAY-To-DAY REVIEW PROCESSES, WHICH INCLUDE THE FOLLOWING: -REVIEWS OF FINANCIAL AND NARRATIVE REPORTS, AUDIT REPORTS, CORRESPONDENCE AND OTHER DOCUMENTATION PROVIDED BY THE GRANTEES -DIRECT COMMUNICATION WITH GRANTEES THROUGH TELEPHONE AND EMAIL FOR QUESTIONS AND TO CHECK ON PROGRESS OF THE PROJECT -ON-SITE VISITS TO THE FIELD SITES TO REVIEW ONE OR MORE ASPECTS OF THE PROJECTS -MONITORING THROUGH AN EXTERNAL AUDIT. A CERTAIN NUMBER OF SUB-GRANTEES ARE SELECTED FOR THE AUDIT EACH YEAR, WHICH IS DONE TO ENSURE FINANCIAL AND EXPENDITURE COMPLIANCE WITH THE RESEARCH AGREEMENT.ExplanationTxt

Schedule G IRS990ScheduleG

Fundraising Event Information FundraisingEventInformationGrp

FieldValueIRS element (for citing)
Event1FUNDRAISINGEvent1Nm
Gross Receipts Event1$28,754GrossReceiptsEvent1Amt
Charitable Contri Event1$28,754CharitableContriEvent1Amt
Gross Receipts Event2$259GrossReceiptsEvent2Amt
Gross Revenue Event2$259GrossRevenueEvent2Amt
Other Direct Expenses Event2$126OtherDirectExpensesEvent2Amt
Other Events Total0OtherEventsTotalCnt
Gross Receipts Total$29,013GrossReceiptsTotalAmt
Charitable Contributions Tot$28,754CharitableContributionsTotAmt
Gross Revenue Total Events$259GrossRevenueTotalEventsAmt
Oth Direct Expnss Total Events$126OthDirectExpnssTotalEventsAmt
Direct Expense Summary Events$126DirectExpenseSummaryEventsAmt
Net Income Summary$133NetIncomeSummaryAmt

Schedule I IRS990ScheduleI

FieldValueIRS element (for citing)
Grant Records MaintainedYes (true)GrantRecordsMaintainedInd

Recipient Table RecipientTable (5 entries)

Address Line1USAddress/AddressLine1TxtCityUSAddress/CityNmState AbbreviationUSAddress/StateAbbreviationCdZIPUSAddress/ZIPCdRecipient EINRecipientEINCash GrantCashGrantAmtPurpose Of GrantPurposeOfGrantTxtIRC SectionIRCSectionDesc
INC RESEARCH LLC
3201 BEECHLEAF CT STE 600RALEIGHNC27604330723120$190,664PROGRAM SERVICE
INNOVATIONS FOR GLOBAL HEALTH
3240 HURON PEAK AVESUPERIORCO80027201059464$66,367PROGRAM SERVICE501(C)(3)
THE ALBERT B SABIN VACCINE INSTITUTE
2000 PENN AVE NWWASHINGTONDC20006061389829$45,117PROGRAM SERVICE501(C)(3)
CHILD HEALTH & RESEARCH FOUNDATION
1 N LEXINGTON AVEWHITE PLAINSNY10601272415391$36,175PROGRAM SERVICE501(C)(3)
BECTON DICKINSON INTERNATIONAL
1 becton drivefranklin lakesNJ07417740003730$15,308PROGRAM SERVICE
FieldValueIRS element (for citing)
Total501c3 Org3Total501c3OrgCnt
Total Other Org2TotalOtherOrgCnt

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferenceMONITORING USE OF GRANTSFormAndLineReferenceDesc
ExplanationTHE IVI IS LOCATED IN SEOUL, KOREA WHERE ALL THE GRANT FUNDS ARE MANAGED AND EXECUTED. THE IVI HAS IN PLACE A VERY DETAILED AND RIGOROUS SYSTEM OF FINANCIAL MONITORING. THIS SYSTEM, WHICH IS EVALUATED BY INTERNAL FINANCE PERSONNEL THROUGHOUT THE YEAR AND AUDITED EXTERNALLY EVERY YEAR, IS USED IN CONJUNCTION WITH CAREFUL PROJECT DEVELOPMENT AND IMPLEMENTATION TO ENSURE ACCOUNTABILITY AND BUDGETARY MANAGEMENT RESPONSIBILITY. FOR SUBGRANTS, THE IVI HAS A BROAD OVERALL SYSTEM OF REVIEWING AND TRACKING THE USE OF GRANTS, AND MORE SPECIFIC DAY-To-DAY REVIEW PROCESSES, WHICH INCLUDE THE FOLLOWING: -REVIEWS OF FINANCIAL AND NARRATIVE REPORTS, AUDIT REPORTS, CORRESPONDENCE AND OTHER DOCUMENTATION PROVIDED BY THE GRANTEES -DIRECT COMMUNICATION WITH GRANTEES THROUGH TELEPHONE AND EMAIL FOR QUESTIONS AND TO CHECK ON PROGRESS OF THE PROJECT -ON-SITE VISITS TO THE FIELD SITES TO REVIEW ONE OR MORE ASPECTS OF THE PROJECTS -MONITORING THROUGH AN EXTERNAL AUDIT. A CERTAIN NUMBER OF SUB-GRANTEES ARE SELECTED FOR THE AUDIT EACH YEAR, WHICH IS DONE TO ENSURE FINANCIAL AND EXPENDITURE COMPLIANCE WITH THE RESEARCH AGREEMENT.ExplanationTxt

Schedule J IRS990ScheduleJ

FieldValueIRS element (for citing)
Travel For CompanionsYes (X)TravelForCompanionsInd
Idemnification Gross Up PmtsYes (X)IdemnificationGrossUpPmtsInd
Housing Allowance Or ResidenceYes (X)HousingAllowanceOrResidenceInd
Personal ServicesYes (X)PersonalServicesInd
Written Policy Ref T And E ExpnssYes (true)WrittenPolicyRefTAndEExpnssInd
Substantiation RequiredYes (true)SubstantiationRequiredInd
Compensation CommitteeYes (X)CompensationCommitteeInd
Written Employment ContractYes (X)WrittenEmploymentContractInd
Compensation SurveyYes (X)CompensationSurveyInd
Board Or Committee ApprovalYes (X)BoardOrCommitteeApprovalInd
Severance PaymentfalseSeverancePaymentInd
Supplemental Nonqual Rtr PlanfalseSupplementalNonqualRtrPlanInd
Equity Based Comp ArrngmfalseEquityBasedCompArrngmInd
Comp Based On Revenue Of Flng OrgfalseCompBasedOnRevenueOfFlngOrgInd
Comp Bsd On Rev Related OrgsfalseCompBsdOnRevRelatedOrgsInd
Comp Bsd Net Earns Flng OrgfalseCompBsdNetEarnsFlngOrgInd
Comp Bsd Net Earns Rltd OrgsfalseCompBsdNetEarnsRltdOrgsInd
Any Non Fixed PaymentsfalseAnyNonFixedPaymentsInd
Initial Contract ExceptionfalseInitialContractExceptionInd

Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (9 entries)

TitleTitleTxtBase Compensation Filing OrgBaseCompensationFilingOrgAmtCompensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmtBonus Filing OrganizationBonusFilingOrganizationAmountBonus Related OrganizationsBonusRelatedOrganizationsAmtOther Compensation Filing OrgOtherCompensationFilingOrgAmtOther Compensation Rltd OrgsOtherCompensationRltdOrgsAmtDeferred Compensation Flng OrgDeferredCompensationFlngOrgAmtDeferred Comp Rltd OrgsDeferredCompRltdOrgsAmtNontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmtNontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmtTotal Compensation Filing OrgTotalCompensationFilingOrgAmtTotal Compensation Rltd OrgsTotalCompensationRltdOrgsAmtComp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmtComp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt
Jerome Kim
Director General$305,481$0$0$0$346,291$0$141,512$0$7,699$0$800,983$0$0$0
Julia Lynch
Deputy Dir. Gen of Dev & delvy$228,333$0$0$0$160,738$0$55,000$0$5,344$0$449,415$0$0$0
Phil Driver
Deputy Dir. Gen of Fin & Ops$252,266$0$0$0$79,395$0$0$0$3,919$0$335,580$0$0$0
In Kyu Yoon
Program Director, MERS and GDA$185,734$0$0$0$122,646$0$58,928$0$13,662$0$380,970$0$0$0
Viliam Pavliak
Head of Vaccine Process Dev$173,432$0$0$0$90,590$0$42,925$0$3,195$0$310,142$0$0$0
Jean-Louis Excler
Head of Clinical Dev & Reg.$180,180$0$0$0$40,953$0$0$0$8,210$0$229,343$0$0$0
Yun Chon
Head of Biostatistics & Data$143,053$0$0$0$74,769$0$35,350$0$1,403$0$254,575$0$0$0
Kyung-Taik Han
Deputy Dir. Gen of Gov Affairs$179,616$0$0$0$30,090$0$0$0$774$0$210,480$0$0$0
Manki Song
Head of Clinical Research Lab$164,955$0$0$0$28,444$0$2,120$0$1,905$0$197,424$0$0$0

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferenceCOMPENSATIONFormAndLineReferenceDesc
ExplanationTRAVEL FOR COMPANION: After 15 months of service, the internationally recruited staff is entitled to home leave travel. This entitlement is an economy round trip between duty station and home base for staff, spouse and dependents under 21. TAX INDEMNIFICATION AND GROSS UP PAYMENTS: IN ORDER TO EQUALIZE THE BENEFITS ACCRUED TO INtERNATIONALLY RECRUITED STAFF, IVI COMPENSATES STAFF WHO ARE OBLIGATED TO PAY TAXES ON IVI DERIVED INCOME TO THEIR HOME COUNTRY. ANY TAX SUBSEQUENTLY LEVIED ON THE AMOUNT OF THE REIMBURSEMENT IS NOT REIMBURSED. IN GENERAL, THIS IS TREATED AS TAXABLE COMPENSATION. HOUSING ALLOWANCE: IVI PROVIDES INTERNATIONALLY RECRUITED STAFF IN KOREA WITH A HOUSING ALLOWANCE UP TO 75% OF A CEILING THAT IS ESTABLISHED AND REVIEWED PERIODICALLY. PERSONAL SERVICES (I.E. driver): IVI PROVIDES THE DIRECTOR GENERAL WITH A DRIVER WHICH is INCLUDED IN HIS/HER EMPLOYMENT CONTRACT PACKAGE APPROVED BY THE BOARD OF TRUSTEES.ExplanationTxt

Schedule L IRS990ScheduleL

Loans Btwn Org Interested Prsn LoansBtwnOrgInterestedPrsnGrp (11 entries)

Relationship With OrgRelationshipWithOrgTxtLoan PurposeLoanPurposeTxtLoan From OrganizationLoanFromOrganizationIndOriginal PrincipalOriginalPrincipalAmtBalance DueBalanceDueAmtDefaultDefaultIndBoard Or Committee ApprovalBoardOrCommitteeApprovalIndWritten AgreementWrittenAgreementInd
JEROME KIM
EMPLOYEEEDUCATIONYes (X)$8,386$5,066falseYes (true)Yes (true)
JULIA LYNCH
EMPLOYEEEDUCATIONYes (X)$14,693$4,597falseYes (true)Yes (true)
JULIA LYNCH
EMPLOYEEHOUSING LOANYes (X)$13,270$1,905falseYes (true)Yes (true)
PHIL DRIVER
EMPLOYEEHOUSING LOANYes (X)$24,934$24,934falseYes (true)Yes (true)
VILIAM PAVLIAK
EMPLOYEEHOUSING LOANYes (X)$16,464$16,464falseYes (true)Yes (true)
FLORIAN MARKS
EMPLOYEEHOUSING LOANYes (X)$25,677$25,677falseYes (true)Yes (true)
SUSHANT SAHASTRABUDDHE
EMPLOYEEHOUSING LOANYes (X)$9,672$7,254falseYes (true)Yes (true)
VINAY KUMAR GUPTA
EMPLOYEEHOUSING LOANYes (X)$5,592$2,424falseYes (true)Yes (true)
SUDEEP KOTHARI
EMPLOYEEEDUCATIONYes (X)$32,153$0falseYes (true)Yes (true)
AYAN DEY
EMPLOYEEHOUSING LOANYes (X)$26,352$26,352falseYes (true)Yes (true)
PAOLA RUSSO
EMPLOYEEHOUSING LOANYes (X)$25,872$25,872falseYes (true)Yes (true)
FieldValueIRS element (for citing)
Total Balance Due$140,545TotalBalanceDueAmt

Schedule M IRS990ScheduleM

FieldValueIRS element (for citing)
Works Of ArtWorksOfArtGrp
Art Historical TreasuresArtHistoricalTreasuresGrp
Art Fractional InterestArtFractionalInterestGrp
Books And PublicationsBooksAndPublicationsGrp
Clothing And Household GoodsClothingAndHouseholdGoodsGrp
Cars And Other VehiclesCarsAndOtherVehiclesGrp
Boats And PlanesBoatsAndPlanesGrp
Intellectual PropertyIntellectualPropertyGrp
Securities Publicly TradedSecuritiesPubliclyTradedGrp
Securities Closely Held StockSecuritiesCloselyHeldStockGrp
Secur Prtnrshp Trust IntrstsSecurPrtnrshpTrustIntrstsGrp
Securities MiscellaneousSecuritiesMiscellaneousGrp
Qualified Contrib Hist StructQualifiedContribHistStructGrp
Qualified Contrib OtherQualifiedContribOtherGrp
Real Estate ResidentialRealEstateResidentialGrp
Real Estate CommercialRealEstateCommercialGrp
Real Estate OtherRealEstateOtherGrp
CollectiblesCollectiblesGrp
Food InventoryFoodInventoryGrp
Drugs And Medical SuppliesDrugsAndMedicalSuppliesGrp
TaxidermyTaxidermyGrp
Historical ArtifactsHistoricalArtifactsGrp
Scientific SpecimensScientificSpecimensGrp
Archaeological ArtifactsArchaeologicalArtifactsGrp

Other Non Cash Contri Table OtherNonCashContriTableGrp

FieldValueIRS element (for citing)
Non Cash CheckboxYes (X)NonCashCheckboxInd
DescROK EQUIPMENTDesc
Contribution0ContributionCnt
Noncash Contributions Rpt F990$26,338NoncashContributionsRptF990Amt
Method Of Determining Revenues0MethodOfDeterminingRevenuesTxt
FieldValueIRS element (for citing)
Any Property That Must Be HeldfalseAnyPropertyThatMustBeHeldInd
Review Process Unusual NC GiftsYes (true)ReviewProcessUnusualNCGiftsInd
Third Parties UsedfalseThirdPartiesUsedInd

Schedule O IRS990ScheduleO

Supplemental Information Detail SupplementalInformationDetail (13 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
FORM 990, PART I, LINE 1IVI'S MISSION IS TO DISCOVER, DEVELOP AND DELIVER SAFE, EFFECTIVE AND AFFORDABLE VACCINES FOR THE WORLD'S DEVELOPING NATIONS. ITS VISION IS DEVELOPING COUNTRIES FREE OF SUFFERING FROM INFECTIOUS DISEASE.
FORM 990, PART III, LINE 1IVI IS THE ONLY INTERNATIONAL ORGANIZATION IN THE WORLD EXCLUSIVELY DEDICATED TO DISCOVERING, DEVELOPING AND DELIVERING VACCINES FOR GLOBAL HEALTH. IVI FOCUSES ON VACCINES AGAINST INFECTIOUS DISEASES OF THE MOST IMPOVERISHED. WE AIM TO MAKE VACCINES AVAILABLE AND ACCESSIBLE FOR VULNERABLE POPULATIONS IN DEVELOPING COUNTRIES. WE LIVE IN AN INCREASINGLY GLOBALIZED WORLD WHERE NEW AND EMERGING INFECTIOUS DISEASES CAN BECOME GLOBAL HEALTH THREATS. IVI ALSO FOCUSES ON VACCINES AGAINST INFECTIOUS DISEASES OF MAJOR GLOBAL HEALTH CONCERN. OUR RESEARCH SPANS THE ENTIRE VACCINE SPECTRUM FROM DISCOVERY AND PRECLINICAL DEVELOPMENT IN OUR SEOUL-BASED LABS TO CLINICAL DEVELOPMENT AT FIELD SITES IN DEVELOPING COUNTRIES TO GENERATING SCIENTIFIC EVIDENCE ON THE NEED FOR VACCINATION IN COUNTRIES WHERE VACCINES ARE MOST NEEDED. OUR HEADQUARTERS IN SEOUL HAVE STATE-OF-THE ART LAB FACILITIES, ANIMAL HOUSE, AND RESEARCH TEAMS THAT INCLUDE CLINICAL IMMUNOLOGY, PROCESS DEVELOPMENT, EPIDEMIOLOGY, CLINICAL & REGULATORY, BIOSTATISTICS & DATA MANAGEMENT, AND POLICY & ECONOMIC RESEARCH. OUTSIDE OF SEOUL, WE HAVE A GLOBAL NETWORK OF FIELD SITES IN MORE THAN 20 COUNTRIES IN ASIA, AFRICA, AND THE AMERICAS. WE MANAGE FIELD SITES IN COLLABORATION WITH REGIONAL AND IN-COUNTRY PARTNERS. WE WORK WITH LOCAL PARTNERS TO IMPLEMENT TRANSLATIONAL AND FIELD RESEARCH PROJECTS, AND WE ALSO PROVIDE TRAINING AND TECHNICAL ASSISTANCE.
FORM 990, PART III, LINE 2Mozambique Cholera Prevention and surveillance(MOCA) is to conduct Cholera Vaccination and Surveillance study in Cuamba district in Mozambique. The goal of this project is to prevent cholera epidemics and empower local public health service for sustainable cholera and other vaccine-preventable disease surveillance and control. korea international Cooperation Agency (KOICA)donated $3,000,000 for 28 months of project duration from June 2017 to September 2019.The three project activities carried out in 2017 under MOCA grant. First, IVI had contract with INS and Wateraid in Mozambique to carry out MOCA project from June 2017 to September 2019. Second, IVI prepared to have import permit on Euvichol in Mozambique and 1st half of 2018, we have received import permit in Mozambique. Euvichol will be used for Cholera Vaccination in July 2018 for more than 180,000 persons (over the age of one year) as target in Cuamba district. The end active, surveillance site assessment was made to discuss and prepare for the surveillance activities in 2018. IVI staff went to Mozambique to select local health care and had official meeting with MOH(INS, Mozambique) for preparation of vaccination campaign and surveillance field work in following year.
FORM 990, PART V, LINE 3GDAC (Global Dengue and Aedes-transmitted Diseases Consortium) is a global alliance to fight Aedes-mosquito-transmitted diseases including dengue, Zika, yellow fever and chikungunya under one strategic umbrella, created in August 2016 by merging the Dengue Vaccine Initiative (DVI) with the Partnership for Dengue Control. Serving as the Secretariat of the consortium, IVI has also been conducted disease burden and epidemiology studies, laboratory testing and policy & access activities. IVI continued to make progress in dengue in 2017. Field studies were completed at all sites, including three studies in Africa, and additional lab testing is underway at IVI. GDAC convened its annual meetings, including the Asia-Pacific Dengue Prevention Board (APDPB) in Thailand in June 2017 and the Americas Dengue Prevention Board (AmDPB) in Brazil in August 2017, where key issues on the topic of "Dengue in the time of Zika" were addressed. GDAC continued working on capacity building with National Regulatory Authorities (NRAs) as well. In addition to the NRAs of "first wave" countries for dengue vaccine registration (Brazil, Colombia, Indonesia, Malaysia, Mexico, Philippines, and Thailand), the NRAs of Vietnam and Sri Lanka were added in 2017. Dengue burden field studies and part of policy & access activities of GDAC funded by Bill & Melinda Gates Foundation were completed as of end 2017; however, other funds from multiple industry partners continue supporting GDAC activities. GDAC also started working with six developing country manufacturer licensees of the US NIH dengue vaccine candidate in 2017, supported by funding from NIH, to develop a central database for clinical trial data generated by the manufacturing licensees.
FORM 990, PART V, LINES 1A AND 2AIVI'S HEADQUARTERS IS BASED IN SEOUL, KOREA. SINCE THE ORGANIZATION IS NOT UNITED STATES BASED, THE ORGANIZATION HAS ONLY FILED (1) FORM W-2 FOR AN EMPLOYEE RESIDING IN THE UNITED STATES. AS OF DECEMBER 31, 2017, THE ORGANIZATION REPORTS 126 EMPLOYEES.
FORM 990, PART V, LINE 4IVI is a foreign organization. It is not required to file Form FinCEN 114 (Report of Foreign Bank and Financial Accounts).
FORM 990, PART VI, LINE 2Adel Mahmoud is a Board member of Inovio Pharmaceuticals where Joseph Kim is a CEO & President at. They are both members of IVI Board of Trustees.
FORM 990, PART VI, LINE 7ADirector General of the Institute is also a voting member of the Board; thus, he/she can participate in the election of the Board.
FORM 990, PART VI, LINE 11BThe finance team makes a first draft of form 990 and the related schedules. HR provides specific information on compensation and other teams provide fundraising, governance and management information. Public accountant prepares the return on IVI's behalf and this is reviewed in turn by the CFO and Deputy CFO for accuracy.
FORM 990, PART VI, LINE 12CTHE IVI HR PROVIDES A COPY OF THE CONFLICT OF INTEREST POLICY TO ALL DIRECTORS, OFFICERS AND STAFF TO COMPLETE ANNUALLY. NOT ONLY PERSONS WITH ACTUAL OR POTENTIAL CONFLICTS OF INTEREST BUT ALSO PERSONS WHO DO NOT HAVE ANY CONFLICTS OF INTEREST MUST SUBMIT A SIGNED COPY OF THE DISCLOSURE OF ACTUAL OR POTENTIAL CONFLICTS OF INTEREST TO THE IVI BOARD SECRETARIAT OR THE IVI HUMAN RESOURCES UNIT AS APPROPRIATE. THE CONFLICT COORDINATOR (DIRECTOR GENERAL) CREATES A CONFLICT COMMITTEE COMPOSED OF THREE OTHER MEMBERS OF THE IVI STAFF TO REVIEW CONFLICT OF INTEREST ISSUES THAT MAY ARISE. THE CONFLICT COMMITTEE SHALL BE RESPONSIBLE FOR ENSURING THAT RELEVANT CONFLICTS OF INTEREST, AND THE PROCEDURES TAKEN TO ELIMINATE, REDUCE OR MANAGE THOSE CONFLICTS, ARE DISCLOSED AT OR PRIOR TO ANY BOARD OF TRUSTEES MEETING. THE COMMITTEE SHALL KEEP A RECORD OF ALL ACTUAL AND POTENTIAL CONFLICTS OF INTEREST AND REPORT ANNUALLY THEREON TO THE BOARD OF TRUSTEES. IN CASE OF TRUSTEES, IVI BOARD SECRETARIAT PROVIDES A COPY OF THE CONFLICT OF INTEREST POLICY TO THE MEMBERS WHEN THEY FIRST JOIN, ALL MEMBERS MUST SUBMIT A SIGNED COPY OF THE DISCLOSURE OF ACTUAL AND POTENTIAL CONFLICTS OF INTEREST TO IVI. THE MEMBERS SHOULD REPORT THEIR CHANGES OF STATUS TO THE BOARD SECRETARIAT.
FORM 990, PART VI, LINES 15A and 15BTHE IVI UNDERTAKES A COMPREHENSIVE COMPENSATION STUDY FOR ITS OFFICERS AND KEY EMPLOYEES. A COMPENSATION CONSULTANT CONDUCTS THE STUDY AND LOOKS AT COMPENSATION AMONG COMPARABLE ORGANIZATIONS WITH SIMILAR POSITIONS AND RESPONSIBILITIES IN ORDER TO PROVIDE MARKET DATA TO DETERMINE IVI STAFF MEMBER COMPENSATION. COMPENSATION IS SET BY INDEPENDENT PERSONS, AND CONTEMPORANEOUS DOCUMENTATION OF THE PROCESS IS RETAINED.
FORM 990, PART VI, LINE 19The IVI's governing documents-Establishment Agreement, Headquarters Agreement, Constitution and Amendments to the Constitution are available on IVI's website. The Summary of financial report is included in IVI's Annual report.
FORM 990, PART XI, LINE 9FOREIGN CURRENCY EXCHANGE GAIN $72,316

Comments

Anonymous: no account or email. Up to 2,000 characters, at most one link. Comments are checked automatically; some wait for review.